基层医疗水平的纤维化-4（FIB-4）评分：对超过16万份血样的分析 - Suppr

Suppr

超能文献

Fibrosis-4 (FIB-4) score at the primary care level: an analysis of over 160 000 blood samples.

作者信息

Petroff David, Bätz Olaf, Jedrysiak Katrin, Kramer Jan, Berg Thomas, Wiegand Johannes

机构信息

Clinical Trial Centre, Leipzig University, Leipzig, Sachsen, Germany.

LADR Laboratory Group Dr Kramer & Colleagues, Geesthacht, Germany.

出版信息

Gut. 2021 Jan;70(1):219-221. doi: 10.1136/gutjnl-2020-320995. Epub 2020 Apr 3.

DOI:10.1136/gutjnl-2020-320995

PMID:32245907

Abstract

摘要

相似文献

Fibrosis-4 (FIB-4) score at the primary care level: an analysis of over 160 000 blood samples.基层医疗水平的纤维化-4（FIB-4）评分：对超过16万份血样的分析

Gut. 2021 Jan;70(1):219-221. doi: 10.1136/gutjnl-2020-320995. Epub 2020 Apr 3.

New scoring system combining the FIB-4 index and cytokeratin-18 fragments for predicting steatohepatitis and liver fibrosis in patients with nonalcoholic fatty liver disease.结合FIB-4指数和细胞角蛋白-18片段的新型评分系统用于预测非酒精性脂肪性肝病患者的脂肪性肝炎和肝纤维化

Biomarkers. 2018 May-Jun;23(4):328-334. doi: 10.1080/1354750X.2018.1425915. Epub 2018 Jan 19.

Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration.在退伍军人健康管理局中识别非酒精性脂肪性肝病的肝纤维化程度。

Dig Dis Sci. 2018 Sep;63(9):2259-2266. doi: 10.1007/s10620-018-5123-3. Epub 2018 May 19.

Diagnosis and Evaluation of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Including Noninvasive Biomarkers and Transient Elastography.非酒精性脂肪性肝病/非酒精性脂肪性肝炎的诊断和评估，包括无创生物标志物和瞬时弹性成像。

Clin Liver Dis. 2018 Feb;22(1):73-92. doi: 10.1016/j.cld.2017.08.004.

Trend over time in hepatic fibrosis score in a cohort of type 2 diabetes patients.2 型糖尿病患者队列中肝纤维化评分的时间趋势。

Diabetes Res Clin Pract. 2018 Jan;135:65-72. doi: 10.1016/j.diabres.2017.10.023. Epub 2017 Oct 31.

Prevalence of Nonalcoholic Steatohepatitis-Associated Cirrhosis in the United States: An Analysis of National Health and Nutrition Examination Survey Data.美国非酒精性脂肪性肝炎相关肝硬化的患病率：基于国家健康与营养检查调查数据的分析

Am J Gastroenterol. 2017 Apr;112(4):581-587. doi: 10.1038/ajg.2017.5. Epub 2017 Feb 14.

Diagnosis of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: Non-invasive tests are enough.诊断非酒精性脂肪性肝病/非酒精性脂肪性肝炎：非侵入性检查足矣。

Liver Int. 2018 Feb;38 Suppl 1:67-70. doi: 10.1111/liv.13658.

Impact of Obesity and Alanine Aminotransferase Levels on the Diagnostic Accuracy for Advanced Liver Fibrosis of Noninvasive Tools in Patients With Nonalcoholic Fatty Liver Disease.肥胖和丙氨酸氨基转移酶水平对非酒精性脂肪性肝病患者无创性工具诊断晚期肝纤维化的准确性的影响。

Am J Gastroenterol. 2019 Jun;114(6):916-928. doi: 10.14309/ajg.0000000000000153.

Screening for non-alcoholic fatty liver disease in type 2 diabetes using non-invasive scores and association with diabetic complications.使用非侵入性评分对2型糖尿病患者进行非酒精性脂肪性肝病筛查及其与糖尿病并发症的关联

BMJ Open Diabetes Res Care. 2020 Feb;8(1). doi: 10.1136/bmjdrc-2019-000904.

Evaluation and comparison of six noninvasive tests for prediction of significant or advanced fibrosis in nonalcoholic fatty liver disease.评价和比较六种非侵入性检测用于预测非酒精性脂肪性肝病中显著或晚期纤维化。

United European Gastroenterol J. 2019 Oct;7(8):1113-1123. doi: 10.1177/2050640619865133. Epub 2019 Jul 12.

引用本文的文献

The Association of Fibrosis-4 Index Scores with Severe Liver Outcomes in Primary Care.纤维 4 指数评分与初级保健中严重肝脏结局的关联。

J Gen Intern Med. 2022 Oct;37(13):3266-3274. doi: 10.1007/s11606-021-07341-z. Epub 2022 Jan 19.

Metabolic dysfunction associated fatty liver disease and coronavirus disease 2019: clinical relationship and current management.代谢功能障碍相关脂肪性肝病与 2019 年冠状病毒病：临床关系和当前管理。

Lipids Health Dis. 2021 Oct 3;20(1):126. doi: 10.1186/s12944-021-01564-z.

Prospective screening of liver fibrosis in a primary care cohort using systematic calculation of fib-4 in routine results.使用 Fib-4 在常规结果中进行系统计算对初级保健队列中的肝纤维化进行前瞻性筛查。

PLoS One. 2021 Jul 22;16(7):e0254939. doi: 10.1371/journal.pone.0254939. eCollection 2021.

Portal Vein Thrombosis in Non-Cirrhotic Non-Alcoholic Fatty Liver Disease: A 9-Year Prospective Cohort Study.非肝硬化非酒精性脂肪性肝病中的门静脉血栓形成：一项为期9年的前瞻性队列研究

Front Med (Lausanne). 2021 Apr 29;8:650818. doi: 10.3389/fmed.2021.650818. eCollection 2021.

Elevation of Liver Fibrosis Index FIB-4 Is Associated With Poor Clinical Outcomes in Patients With COVID-19.肝纤维化指数 FIB-4 升高与 COVID-19 患者的临床预后不良相关。

J Infect Dis. 2020 Aug 4;222(5):726-733. doi: 10.1093/infdis/jiaa355.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验